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Objectives This study sought to determine the relationship between vascular disease in different arterial territories and
advanced age.
Background Vascular disease in the peripheral circulation is associated with significant morbidity and mortality. There is little
data to assess the prevalence of different phenotypes of vascular disease in the very elderly.
Methods Over 3.6 million self-referred participants from 2003 to 2008 who completed a medical and lifestyle question-
naire in the United States were evaluated by screening ankle brachial indices 0.9 for peripheral artery disease
(PAD), and ultrasound imaging for carotid artery stenosis (CAS) 50% and abdominal aortic aneurysm (AAA)
3 cm. Participants were stratified by decade of life. Multivariate logistic regression analysis was used to esti-
mate odds of disease in different age categories.
Results Overall, the prevalence of PAD, CAS, and AAA, was 3.7%, 3.9%, and 0.9%, respectively. Prevalence of any vascu-
lar disease increased with age (40 to 50 years: 2%, 51 to 60 years: 3.5%, 61 to 70 years: 7.1%, 71 to 80 years:
13.0%, 81 to 90 years: 22.3%, 91 to 100 years: 32.5%; p  0.0001). Prevalence of disease in each vascular
territory increased with age. After adjustment for sex, race/ethnicity, body mass index, family history of cardio-
vascular disease, smoking, diabetes, hypertension, hypercholesterolemia, and exercise, the odds of PAD (odds
ratio [OR]: 2.14; 95% confidence interval [CI]: 2.12 to 2.15), CAS (OR: 1.80; 95% CI: 1.79 to 1.81), and AAA
(OR: 2.33; 95% CI: 2.30 to 2.36) increased with every decade of life.
Conclusions There is a dramatic increase in the prevalence of PAD, CAS, and AAA with advanced age. More than 20% and
30% of octogenarians and nonagenarians, respectively, have vascular disease in at least 1 arterial territory.
(J Am Coll Cardiol 2013;61:1736–43) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.054Peripheral vascular disease (PVD) is associated with signif-
icant morbidity and mortality (1–4). Understanding the
relationship between risk factors and disease prevalence may
help better guide preventive and risk reduction strategies.
Increasing age is a well-known risk factor for atherosclero-
sis. Increasing age is the strongest determinant of heart
disease and stroke risk in multiple risk factor algorithms.
However, the precise association of advanced chronological
age in vascular disease of different peripheral arterial loca-
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2012, accepted January 8, 2013.tions is less well studied. Most data on the epidemiology of
peripheral vascular disease are from small screening studies
or meta-analyses, which included few older adults, particu-
larly octogenarians and nonagenarians (5–9). Furthermore,
most reports were limited such that they combined data from
several studies with varying definitions of disease and did not
investigate different phenotypes of vascular disease in a single
population. To better understand the relationship between
advanced age and peripheral vascular disease, we sought to
determine the prevalence of peripheral artery disease (PAD),
carotid artery stenosis (CAS), and abdominal aortic aneurysms
(AAA) stratified by decade of life in a single large population-
based study including over 3.6 million subjects.
Methods
Study population. The study was based on data provided
by Life Line Screening Inc. (Independence, Ohio) to the Society
for Vascular Surgery for research purposes. The study cohort
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April 23, 2013:1736–43 Advanced Age and Vascular Disease Territoriesconsists primarily of self-referred individuals who paid for vascular
screening tests out of pocket. Screenings were performed from
2003 to 2008 at more than 20,000 sites nationwide. Before
undergoing the screening procedure, individuals completed an
extensive questionnaire that included information on demograph-
ics, smoking, exercise, cardiovascular risk factors, medical comor-
bidities, and family history of atherosclerosis and vascular disease.
Ascertainment of PVD. PAD, CAS, and AAA were
determined with simple noninvasive procedures that have
high sensitivity and specificity: the ankle brachial index
(ABI), carotid Duplex ultrasound, and abdominal ultra-
sound, respectively (10). Systolic blood pressure was mea-
sured in both arms (brachial arteries) and both ankles
(posterior tibial arteries). If a posterior tibial Doppler signal
was inaudible, the dorsalis pedis artery signal was measured.
Left and right ABI measurements were obtained by divid-
ing the ankle systolic blood pressure by the highest arm
pressure. PAD was defined as an ABI 0.90 in either leg,
and subjects with an ABI 1.4 were excluded because these
values may be falsely elevated due to calcification of the
arterial wall (11). CAS was defined by carotid artery stenosis
50% in either (or both) internal carotid arteries (internal
carotid artery peak systolic velocity125 cm/s). The greater
of the anteroposterior or transverse ultrasound–based mea-
surements of the infrarenal abdominal aorta was used to
identify aortic size. AAA was defined by a diameter of the
abdominal aorta 3 cm.
Symptomatic PAD is defined by aching or pain in the
egs that is worse with walking or running, or that is relieved
n a few minutes by rest, or a prior lower extremity
evascularization. Symptomatic CAS is defined by a history
f stroke, transient ischemic attack, or prior intervention on
he carotid arteries. Symptomatic AAA is defined by a prior
rocedure to repair a AAA.
uality control. All Life Line sites utilize identical proto-
cols and are subject to the quality control program. Included
in this program are random monthly audits where ultra-
sonography images are graded for each team and individual
performance is tracked. Physician audits are performed on a
quarterly basis. All results are processed by the results center
and outliers are all reviewed. Percentage of abnormal find-
ings is tracked per team to identify groups finding abnor-
mally high or low number of disease cases. A clinical
leadership team holds monthly review meetings to evaluate
performance of teams and individual members. For imaging
modalities, annual competencies are performed and all new
employees must have demonstrated initial competencies
before being allowed to perform testing without supervision.
Other variables of interest. Hypertension was defined as
systolic blood pressure of 140 mm Hg or greater in upper
extremity, prior physician diagnosis, or medication use.
Hypercholesterolemia was defined as physician diagnosis or
medication use. Diabetes was defined as self-reported phy-
sician diagnosis or the use of diabetes medication. Subjects
who had smoked 100 cigarettes during their lifetime and
were still currently smoking were considered smokers. ySubjects who reported engage-
ment in some kind of vigorous
leisure time exercise at least once
per week were considered active
and all other subjects were con-
sidered sedentary. Race and eth-
nicity were self-reported.
Statistical analysis. We calcu-
lated the proportion of participants
affected with vascular disease
across discrete age groups (40 to
50 years, 51 to 60 years, and so on)
and examined sex-specific preva-
lence of vascular disease. We
tested for trends with the
Cochran-Armitage test (12). The corresponding 95% con-
fidence intervals (CIs) were reported to present uncertainty
associated with the estimated prevalence.
Logistic regression models were used to determine the
association between risk factors and vascular phenotypes.
Age was included as a categorical variable broken down by
age deciles (40 to 50 years, 51 to 60 years, 61 to 10 years,
71 to 80 years, 81 to 90 years, 91 to 100 years). Univariate
analysis was used to describe the association of age with
the 3 types of peripheral vascular diseases and multivariate
analysis was used to accommodate other risk factors. The odds of
PAD and CAS for subjects in each age decile were
determined by comparing to the 40 to 50 years of age
group. For AAA, subjects were compared to the 40 to 60
year age group given the very low prevalence among 40-
to 50-year-olds. To test for linear trend, age groups were
included as a single continuous variable in the logistic
regression model.
Regression analysis. To estimate the precise relationship
between age and different peripheral vascular disease pheno-
types, prevalence values from each disease were plotted against
age. Prevalence of AAA, CAS, and PAD was defined as count
per 100,000. Prevalence of disease as a function of age was
presented using scatter plots. Age was defined on the basis of
55 strata. The first stratum corresponded to subjects aged 40.
All subsequent strata were on the basis of 1-year age incre-
ments beginning with 41 years of age. Linear regression model
was employed to examine trends in AAA, CAS, and PAD
prevalence. Because prevalence of PAD and CAS had a right
skewed distribution, estimation and inference for PAD and
CAS was on the basis of the log scale. Uncertainty associated
with the estimated trend was presented using 95% CIs of the
regression line.
Results
We analyzed data on 3,613,381 subjects age 40 years and
older. Overall, the mean age of the overall population was
64.1  10.2 years of age. The population included 205,593
ubjects age 81 to 90 years and 10,129 subjects age 91 to 100
Abbreviations
and Acronyms
AAA  abdominal aortic
aneurysm
ABI  ankle brachial index
CAS  carotid artery
stenosis
CI  confidence interval
OR  odds ratio
PAD  peripheral artery
disease
PVD  peripheral vascular
diseaseears. Baseline characteristics of the study population are
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Advanced Age and Vascular Disease Territories April 23, 2013:1736–43provided for each age decile (Table 1). As expected, risk
factors for cardiovascular disease increased with increasing
age. However, several risk factors decreased in the octo- and
nonagenarians groups. For example, diabetes and hypercho-
lesterolemia increased with advanced age until 80 years of
age and declined thereafter.
In the overall population, any type of peripheral vascular
disease was present in 7.48% (95% CI: 7.44% to 7.51%).
The prevalence of any vascular disease increased signifi-
cantly with age (Fig. 1) ranging from 2.0% (1 in 50) in the
40 to 50 years age category to 32.0% (1 in 3) in the 91 to
100 years age category. Among octogenarians and nonage-
narians, more than 20% and 30%, respectively, had periph-
eral vascular disease in at least 1 arterial territory. The
General Characteristics of the 3.6 Million Subjects in Whom PVD WTable 1 General Characteristics of the 3.6 Million Subjects in
Characteristic
Overall
(n  3,613,381)
40–50
(n  333,369)
51–60
(n  1,023,
Demographics
Age 64.1 10.2 46.7 2.8 56.1 2
Male 35.7 35.9 33.5
Caucasian 89.1 85.5 88.4
Black 3.1 4.3 3.6
Hispanic 2.4 4.4 3.1
Asian 2.0 3.2 2.5
Native American 2.9 1.7 1.7
Other 0.6 1.1 0.7
BMI 27.7 5.4 28.3 6.0 28.3 5
Medical history
Hypertension 47.0 28.0 38.9
Diabetes 10.9 5.4 8.4
Current smoker 24.9 27.8 26.2
Cholesterol 53.4 39.1 50.2
Exercise 41.9 41.4 41.6
Family history of
CVD
23.0 23.6 23.8
Values are mean  SD or %.
BMI  body mass index; CVD  cardiovascular disease; PVD  peripheral vascular disease.
Figure 1
Prevalence of Any Vascular Disease
(Peripheral Artery Disease, Abdominal Aortic
Aneurysm, or Carotid Artery Stenosis) by Age Decile
Prevalence of any vascular disease increased with age (40 to 50 years:
2%, 51 to 60 years: 3.5%, 61 to 70 years: 7.1%, 71 to 80 years: 13.0%,
81 to 90 years: 22.3%, 91 to 100 years old: 32.5%; p for trend 0.0001).association between increasing age and any peripheral vas-
cular disease was similar in women (40 to 50 years: 2.37%,
51 to 60 years: 3.59%, 61 to 70 years: 6.51%, 71 to 80 years
old: 11.75%, 81 to 90 years: 20.34%, 91 to 100 years:
31.58%; p for trend 0.001) and men (40 to 50 years:
1.44%, 51 to 60 years: 3.44%, 61 to 70 years: 8.02%, 71 to
80 years: 15.25%, 81 to 90 years: 26.03%, and 91 to 100
years: 34.44%; p for trend 0.001).
Among all individuals, prevalence of PAD, CAS, AAA
was present in 3.68% (95% CI: 3.66% to 3.70%), 3.86%
(95% CI: 3.84% to 3.88%), and 0.88% (95% CI: 0.87% to
0.89%) of subjects, respectively. In each vascular territory,
prevalence of disease increased substantially with advanced
age (Fig. 2), ranging from 1.2% to 24.1% for PAD, 0.9% to
11.3% for CAS, and 0.05% to 3.5% for AAA between the
lowest (40 to 50 years) and highest (91 to 100 years) age
categories. Association between age and vascular disease was
significant for both symptomatic and asymptomatic subjects
(Online Table 1). Prevalence data by age was plotted to
determine trends in the prevalence of PAD, CAS, and
AAA. Regression analysis calculated a formula for a sub-
ject’s prevalence of a particular disease with respect to age
(Fig. 3). The coefficient of determination (r2) for the PAD,
CAS, and AAA regression models are 0.98, 0.96, and 0.90,
respectively. The prevalence of PAD and CAS follow an
exponential curve, increasing dramatically with advanced
age, while the prevalence of AAA increases linearly with
advanced age. Prior to age 55 years, CAS and PAD show a
similar prevalence. From age 55 years to approximately
age 78 years, the prevalence of CAS is greater than PAD,
while after age 78 years, the prevalence of PAD increases
substantially and its prevalence far outweighs that of
ssessedPVD Was Assessed
61–70
(n  1,268,912)
71–80
(n  771,672)
81–90
(n  205,593)
91–100
(n  10,129)
65.3 2.8 74.9 2.8 83.9 2.5 92.8 2.0
37.0 36.7 35.0 32.9
90.2 90.2 87.5 85.0
2.9 2.4 2.3 3.5
2.1 1.4 1.0 0.9
1.8 1.2 0.8 0.8
2.4 4.3 7.8 9.1
0.5 0.5 0.7 0.8
27.9 5.3 26.9 4.7 25.5 4.3 24.4 4.2
50.0 57.5 60.0 56.5
12.0 14.2 13.2 10.7
25.4 22.3 19.8 17.0
57.4 58.0 50.3 36.5
43.8 41.5 33.8 27.2
22.4 22.4 22.8 21.3as Ahom
706)
.8
.7CAS. AAA has a lower prevalence that CAS or PAD for
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phenotypes deviate from the predicted curve after 90
years of age.
The unadjusted odds ratios (ORs) associated with age
deciles of 40 to 50 (reference group), 51 to 60, 61 to 70, 71
to 80, 81 to 90, and 91 to 100 years of age were 1, 1.51,
2.72, 5.76, 13.52, and 27.26 (p for trend 0.001) for PAD;
1, 2.04, 4.49, 8.14, 12.10, and 14.34 (p for trend 0.001)
for CAS; and 1, 1, 4.78, 9.95, 14.81, and 19.8 (p for trend
0.001) for AAA, respectively. A similar relationship
between age and vascular disease was demonstrated in
Figure 2 Sex-Specific Prevalence of
PAD, CAS, and AAA by Age Decile
Prevalence of (A) peripheral artery disease (PAD), (B) carotid artery stenosis
(CAS), and (C) abdominal aortic aneurysm (AAA) increased with age in both
women and men, respectively (p for trend 0.0001 for each comparison).women and men, respectively (Table 2).Following adjustment for sex, race/ethnicity, body mass
index, smoking, hypertension, physical activity, hypercho-
lesterolemia, diabetes, and family history of cardiovascular
disease, the ORs associated with age decile were 1, 1.37,
2.27, 4.84, 12.03, and 26.70 (p for trend 0.001) for PAD;
1, 1.77, 3.39, 5.83, 8.88, and 11.57 (p for trend 0.001) for
CAS; and 1, 1, 3.97, 8.34, 13.58, and 21.37 (p for trend
0.001) for AAA, respectively. The association between
age and disease was more apparent for men in PAD and
CAS and more apparent for women in AAA (Table 3).
Compared to subjects in the youngest age category,
octogenarians were approximately 12-fold likely to have
PAD (OR: 12.03; 95% CI: 11.54 to 12.54), nearly 9-fold
likely to have CAS (OR: 8.88; 95% CI: 8.48 to 9.30) and
nearly 14-fold likely to have an AAA (OR: 13.58; 95% CI:
12.82 to 14.39). Nonagenarians were nearly 27-fold likely to
have PAD (OR: 26.70; 95% CI: 24.78 to 28.75), 12-fold
likely to have CAS (OR: 11.57; 95% CI: 10.56 to 12.66),
and over 21-fold likely to have an AAA (OR: 21.37; 95%
CI: 18.42 to 24.68).
Following multivariable adjustment, the ORs for the
association of peripheral vascular disease with increasing age
(per 10-year increments) were significant for PAD (OR:
2.14; 95% CI: 2.12 to 2.15), CAS (OR: 1.80; 95% CI: 1.79
to 1.81), and AAA (OR: 2.33; 95% CI: 2.30 to 2.36)
(Fig. 4).
Polyvascular disease increased with increasing age as well;
vascular disease in more than 1 location was 0.04% in the 40
Figure 3 Prevalence of PAD, CAS, and AAA by Age
Prevalence of each disease phenotype was defined as count per 100,000 and
presented using scatter plots. Regression analysis calculated a formula for a
subject’s prevalence of a particular disease with respect to age. The coefficient
of determination (r2) for the PAD, CAS, and AAA regression models are 0.98, 0.96,
and 0.90, respectively. Solid black line  PAD; dashed black line  95% confi-
dence interval of PAD; solid red line  CAS; dashed red line  95% confidence
interval of CAS; solid blue line  AAA; dashed blue line  95% confidence
interval of AAA. Abbreviations as in Figure 2.
Unadjusted Odds Ratio of Age and Sex for PAD, CAS, and AAATable 2 Unadjusted Odds Ratio of Age and Sex for PAD, CAS, and AAA
PAD CAS AAA
Overall Female Male Overall Female Male Overall Female Male
40–50 yrs 1.00 1.00 1.00 1.00 1.00 1.00 1.00* 1.00* 1.00*
51–60 yrs 1.51 (1.45–1.57) 1.36 (1.30–1.43) 2.02 (1.86–2.21) 2.04 (1.96–2.13) 1.85 (1.75–1.95) 2.48 (2.30–2.69) 1.00* 1.00* 1.00*
61–70 yrs 2.72 (2.62–2.83) 2.32 (2.22–2.42) 4.34 (3.99–4.71) 4.49 (4.31–4.69) 3.82 (3.63–4.02) 5.96 (5.54–6.43) 4.78 (4.55–5.02) 5.49 (4.87–6.21) 4.31 (4.09–4.56)
71–80 yrs 5.76 (5.55–5.98) 4.78 (4.58–4.99) 9.67 (8.91–10.51) 8.14 (7.81–8.49) 6.69 (6.36–7.04) 11.31 (10.51–12.20) 9.95 (9.48–10.45) 14.2 (12.66–16.01) 8.56 (8.11–9.03)
81–90 yrs 13.52 (13.00–14.07) 10.93 (10.45–11.43) 23.77 (21.86–25.90) 12.10 (11.58–12.66) 9.57 (9.07–10.11) 17.94 (16.62–19.41) 14.81 (14.02–15.65) 23.17 (20.43–26.36) 12.94 (12.16–13.76)
91–100 yrs 27.26 (25.40–29.25) 22.86 (21.01–24.85) 44.20 (38.62–50.57) 14.34 (13.14–15.64) 12.26 (10.98–13.66) 19.32 (16.67–22.33) 19.80 (17.19–22.69) 38.83 (29.98–49.66) 16.79 (14.11–19.84)
Values are odds ratio (95% confidence interval). *40 to 60 used as a reference.
AAA  abdominal aortic aneurysm; CAS  carotid artery stenosis; PAD  peripheral artery disease.
Adjusted Odds Ratio of Age and Sex for PAD, CAS, and AAATable 3 Adjusted Odds Ratio of Age and Sex for PAD, CAS, and AAA
PAD CAS AAA
Overall Female Male Overall Female Male Overall Female Male
40–50 yrs 1.00 1.00 1.00 1.00 1.00 1.00 1.00* 1.00* 1.00*
51–60 yrs 1.37 (1.32–1.43) 1.28 (1.22–1.34) 1.69 (1.54–1.84) 1.77 (1.69–1.85) 1.61 (1.52–1.70) 2.12 (1.96–2.30) 1.00* 1.00* 1.00*
61–70 yrs 2.27 (2.19–2.37) 2.02 (1.94–2.12) 3.13 (2.88–3.40) 3.39 (3.25–3.54) 2.91 (2.76–3.06) 4.45 (4.12–4.80) 3.97 (3.78–4.18) 4.85 (4.29–5.50) 3.8 (3.60–4.02)
71–80 yrs 4.84 (4.65–5.03) 4.27 (4.09–4.47) 6.58 (6.05–7.16) 5.83 (5.59–6.09) 4.84 (4.60–5.11) 7.93 (7.35–8.56) 8.34 (7.94–8.78) 12.65 (11.22–14.32) 7.55 (7.15–7.99)
81–90 yrs 12.03 (11.54–12.54) 10.58 (10.09–11.1) 16.09 (14.76–17.58) 8.88 (8.48–9.30) 7.11 (6.72–7.52) 12.61 (11.65–13.68) 13.58 (12.82–14.39) 22.2 (19.45–25.41) 11.98 (11.23–12.78)
91–100 yrs 26.70 (24.78–28.75) 24.33 (22.26–26.58) 33.33 (28.94–38.36) 11.57 (10.56–12.66) 9.83 (8.76–11.00) 15.15 (13.01–17.59) 21.37 (18.42–24.68) 40.85 (31.12–52.9) 17.37 (14.51–20.63)
Values are odds ratio (95% confidence interval). *40 to 60 used as a reference.
Abbreviations as in Table 2.
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April 23, 2013:1736–43 Advanced Age and Vascular Disease Territoriesto 50 years old age group, 0.19% in the 51 to 60 years age
group, 0.66% in the 61 to 70 years age group, 1.7% in the
71 to 80 years age group, 3.58% in the 81 to 90 years age
group, and 6.56% in the 91 to 100 years age group (p for
trend 0.001). Overlap of vascular disease by decade is
llustrated in the Online Figure 1.
iscussion
his study demonstrates the striking association between
ncreasing age and prevalence of peripheral vascular disease
n different vascular territories. Using data from a
opulation-based screening study of more than 3.6 million
eople in the United States, we were able to include data
rom more than 200,000 individuals older than age 80 years
aking this by far the largest study of age and peripheral
ascular disease. There are several important findings in this
aper. First, the prevalence of any peripheral vascular
isease increased from 1 in 50 in the 40 to 50 years old age
roup to nearly 1 in 3 in the 91 to 100 years old age group.
econd, the prevalence of each type of PVD (PAD, CAS,
nd AAA) increased considerably with advanced age overall
nd for women and men, respectively. Third, the association
etween age and PVD remained even after adjustment for
aseline demographics and clinical risk factors. For every
0-year increase in age, the odds of PAD (2.14), CAS
1.80), and AAA (2.33) increased significantly. Finally,
hile the prevalence of PAD, CAS, and AAA increased
ith advanced age, each disease type acted differently across
he spectrum of age.
There is a well-established relationship between age and
oronary artery disease. The Framingham and other cardio-
ascular risk scores place a significant emphasis on the
ubjects’ age in determining the individuals’ risk for a
oronary event (13,14). While it is well known that a
Figure 4 Adjusted Odds Ratio for Vascular Disease
by Each Decade of Life
Adjusted odds ratio with 95% confidence intervals for PAD, AAA, and CAS after
adjustment for age (every 10 years), sex, race/ethnicity, body mass index,
smoking, hypertension, physical activity, hypercholesterolemia, diabetes, and
family history of cardiovascular disease. Odds ratio 1.0 indicates that the
prevalence of vascular disease increases with increased age.ubjects’ risk of atherosclerotic disease increases with age,the precise relationship between age and peripheral vascular
disease in different vascular territories is less well known.
Most prior studies of age and peripheral vascular disease
examined the prevalence of PAD. As expected, several
studies demonstrated the prevalence of PAD increases with
age (5,6,15–22), ranging from 0% among 60- to 69-year-
olds (22) to over 50% among subjects over 85 years of age
(6). The most likely explanations for the reported variability
in prevalence are the different populations evaluated (e.g.,
hyperlipidemia [5] and nursing home population [6]),
different diagnostic criteria for PAD (5), or imprecision due
to the limited small sample size (18,19). For example, the
study by Criqui et al. included subjects with hyperlipidemia
and reported a 33.8% prevalence of PAD in subjects age 70
to 82 years; however, PAD was defined by either ABI 0.8
or abnormal flow velocities (5). In a more representative
population, the Cardiovascular Health Study (18) and
National Health and Nutritional Examination Survey (19)
studies demonstrated an increase in PAD with advanced
age. However, the Cardiovascular Health Study and Na-
tional Health and Nutritional Examination Survey studies
included only 184 and 779 individuals over the age of 85
years, respectively, thus limiting the generalizability to the
octogenarian and nonagenarian populations.
Fewer reports have investigated the relationship between
age and carotid artery disease and abdominal aortic aneu-
rysms. While CAS studies have noted an association be-
tween disease and age (23–25), ranging from 1.2% among
60- to 69-year-olds (23) to over 11% among subjects 85
years old or older (25), no study included subjects 90 years
old and older and the reported studies utilized varied
definitions of clinical CAS ranging from 35% (24) to 60%
(23) stenosis.
An association between advanced age and AAA has been
noted as well (9,26–28), ranging from 1% among 60- to
64-year-olds (9) to 15% among subjects over 75 years of age
(26). Unfortunately, significant representation among older
adults is lacking among these studies as well, with only 1
study including subjects over 80 years of age (28). With
more than 3 million subjects (of whom 200,000 are greater
than 80 years of age), we provide important prevalence data
on older adults lacking from previous PAD, CAS, and
AAA reports.
In all 3 arterial territories, prevalence was highest among
the oldest age groups. Atherosclerosis is considered the
main contributor to vascular disease and is known to
increase with age (29). Increased prevalence and severity of
atherosclerosis risk factors are thought to explain this
progression (30). Yet, in older adults, certain risk factors
declined in our study. For example, the prevalence of
diabetes and hyperlipidemia increased until 80 years of age
and then declined suggesting a survival bias in our popula-
tion. Nonetheless, the prevalence of vascular disease in-
creased until approximately 95 years of age (Fig. 3). Physical
activity is considered antiatherogenic (31), and declined in
our population after age 70 years, which may contribute to
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Moreover, vascular dysfunction has been shown to in-
crease with age because of decreased compliance (32),
angiogenesis (33–35), endothelial antithrombotic prop-
erties (36,37), and increased inflammation (32), possibly
due to vascular endothelial cell senescence (38), which
also increases with age.
Interestingly, all 3 vascular diseases show different pat-
terns of progression with advanced age (Fig. 2). Both CAS
and PAD result from systemic atherosclerosis, yet PAD was
far more prevalent among older subjects. It is possible that
the differences in progression of disease are simply due to
the diagnostic criteria used to determine disease prevalence;
an ABI 0.9 may only represent mild stenosis in the lower
xtremity peripheral vasculature, whereas the CAS cutoff
hat we utilized (50% stenosis) represents comparatively
ore advanced disease. Alternatively, the ABI may be
alsely lower in the very elderly due to aortic disease, thus
verestimating the burden of PAD in the very elderly.
inally we cannot exclude a survivor effect whereby those
atients with significant atherosclerosis developed fatal
troke or myocardial infarction and thus the prevalence of
AS is not as high in the oldest old age groups. AAAs are
ess prevalent than CAS or PAD among all age groups,
ossibly due to a mechanism independent of atherosclerosis
39).
imitations and strengths. This observational and cross-
ectional study provides no longitudinal data including
ong-term follow-up to evaluate outcomes and determine
hether identifying PVD changed the course of the disease.
urthermore, a single measure of vascular disease was
tilized, thus not identifying individuals with disease who
equire additional techniques for diagnosis. Although the
egression analysis in Figure 3 could be useful in assessing
he likelihood of someone having a particular vascular
isease, there is uncertainty in the oldest ages. Finally, this
tudy included a self-selected population of subjects willing
o pay for the diagnostic tests out of pocket and thus may
ot be generalized to other populations. While the preva-
ence of disease may be altered by the symptom status of
ubjects included, the association between age and preva-
ence of disease should not differ. In fact, the association
etween age and vascular disease was present for both
ymptomatic and asymptomatic vascular disease (Online
able 1). It is worthwhile to point out that the prevalence of
ifferent cardiovascular risk factors in this database were
imilar to those of the general population (Online Table 2).
The main strengths of this study include its large popu-
ation size, wide age representation, availability of lifestyle
nd medical data, and evaluation of 3 vascular diseases all in
he same population. Furthermore, the individual age prev-
lence values and equations with high r2 values in Figure 3
rovide a unique tool for clinicians to assess the likelihood
f any of the 3 vascular diseases being present in the patient.onclusions
n a large database of more than 3.6 million self-referred
ndividuals, we conclude that peripheral vascular disease is
ommon and strongly associated with increased chronolog-
cal age. In all vascular territories examined, prevalence
ncreased significantly with age, but a trend of progression
aried among different vascular disease phenotypes. The
igh prevalence of PVD illustrates the need to further
esearch potential benefits of screening and treatment in
ppropriately aged populations.
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For supplemental tables and figures,
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